Zimmer Biomet (ZBH)
(Delayed Data from NYSE)
$106.34 USD
+0.06 (0.06%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $106.32 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum C VGM
Brokerage Reports
0 items in cart
Zimmer Biomet Holdings, Inc. [ZBH]
Reports for Purchase
Showing records 41 - 60 ( 202 total )
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Hyaluronic Acid Overview and Reimbursement Changes
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department